Exciting news for preventive healthcare: a European research consortium has unveiled a new wearable device capable of continuous glucose monitoring (CGM) for non-diabetic individuals. This innovation promises to provide deeper insights into metabolic health beyond traditional diabetic care.

The device, recently showcased at a leading medical technology conference, uses advanced biosensor technology to track real-time glucose fluctuations, helping users and clinicians identify early markers of metabolic disorders.

Experts believe this breakthrough could transform lifestyle interventions, nutrition planning, and early detection of metabolic syndrome for millions.

Learn more about this development and its potential impact on routine health management across Europe and globally.